Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIPS-A: Aspirin for ARDS Prevention
NCT01504867Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2012
- Primary completion
- Sep 2015
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin throat spray + placebo in acute respiratory distress syndrome (ARDS), sponsored by Mayo Clinic. Started Jan 2012; status: completed.
02
Drugs
aspirin throat spray + placebo
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT01504867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01504867.